Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,032.00. The company's market cap stands at 976.31B, with a P/E ratio of 53.27 and a dividend yield of 55.7%.
On 2026-01-15, Eli Lilly(LLY) stock moved within a range of $1,012.57 to $1,069.60. With shares now at $1,032.00, the stock is trading +1.9% above its intraday low and -3.5% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 4.18M, versus its average volume of 3.03M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
If you are wondering whether Eli Lilly's share price still reflects fair value after a strong multi year run, you are not alone. The stock closed at US$1,032.9...
Eli Lilly dipped after a report that FDA approval of its weight loss pill is delayed to Q2. The pharma company was also in the news as a lawsuit from Strive Spe...
Eli Lilly And Co (NYSE:LLY) shares are trading lower on Thursday. The company, along with Novo Nordisk (NYSE:NVO) , are reportedly being sued in Texas by compou...
Analyst ratings
79%
of 29 ratingsMore LLY News
Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs. Strive Specialties, one of t...
The stock of pharmaceutical giant Eli Lilly (LLY) is down 5% on news that the U.S. Food and Drug Administration (FDA) has delayed a decision on whether to appro...
The Food and Drug Administration pushed back by two weeks a review of Disc Medicine’s (IRON) experimental drug for a rare blood disorder following concerns abou...
Key Points Eli Lilly's weight-loss drugs are experiencing rapid growth. It still has a long way to go to help curb obesity rates around the globe. The stock...
NVIDIA Corp.’s (NASDAQ:NVDA) and Eli Lilly and Co.'s (NYSE:LLY) newly announced $1 billion AI co-innovation lab underscores how artificial intelligence is sprea...
Plenty of growth lies ahead for these top healthcare companies. What makes a winning healthcare stock? One that is a leader in its industry and has proven its...
For speculative investors, the start of each year is always a good time to revisit an initial public offering (IPO) calendar. Almost every week, companies go pu...
